Skip to main content
Erschienen in: Lung 3/2020

07.04.2020 | LUNG VOLUME REDUCTION

Cardio-Pulmonary Changes After Bronchoscopic Lung Volume Reduction with Endobronchial One-Way Valves

verfasst von: Alfonso Fiorelli, Roberto Cascone, Giovanni Natale, Valentina Peritore, Camilla Vanni, Camilla Poggi, Federico Venuta, Erino Angelo Rendina, Mario Santini, Claudio Andreetti

Erschienen in: Lung | Ausgabe 3/2020

Einloggen, um Zugang zu erhalten

Abstract

Introduction

To evaluate the cardio-pulmonary hemodynamics changes before and after valve treatment, and their correlation with lobe volume reduction.

Methods

This retrospective multicentre study included consecutive patients undergoing bronchoscopic valve treatment for heterogeneous emphysema. In addition to standard functional evaluation, patients underwent cardiac evaluation by Doppler trans-thoracic echocardiography. The difference in respiratory and cardio-pulmonary hemodynamics indexes before and 3-month after the procedure, and their relationship with changes in lobar volume were evaluated.

Results

Seventy-seven patients were included in the study; of these 13 (17%) presented pulmonary hypertension. Only patients with target lobar volume reduction ≥ 563 mL (n = 50) presented a significant improvement of forced expiratory volume in one second, residual volume, 6 min-walk test, and St. George’s Respiratory Questionnaire score; a significant reduction of pulmonary artery pressure, and an improvement of left and right ventricle end-systolic volume; of left and right ventricle end-diastolic volume, and of left and right ventricle stroke volume. The change in residual volume was significantly correlated with changes in forced expiratory volume in one second (r = 0.68; p < 0.001); in 6 min-walk test (r = 0.71; p < 0.001); in St. George’s Respiratory Questionnaire (r = 0.54; p < 0.001); in pulmonary artery pressure (r = 0.39; p = 0.001), in left (r = 0.28; p = 0.01) and right (r = 0.33; p = 0.002) ventricle end-systolic volume, in left (r =  − 0.29; p = 0.008) and right (r =  − 0.34; p = 0.007) end-diastolic volume, and in left (r =  − 0.76; p = 0.009) and right (r =  − 0.718; p = 0.001) ventricle stroke volume.

Conclusion

Bronchoscopic valve treatment seemed to have positive effects on cardio-pulmonary hemodynamics, and these changes were correlated with reductions of lobar volume.
Literatur
1.
Zurück zum Zitat Fiorelli A, D'Andrilli A, Anile M et al (2016) Sequential bilateral bronchoscopic lung volume reduction with one-way valves for heterogeneous emphysema. Ann Thorac Surg 102:287–294CrossRef Fiorelli A, D'Andrilli A, Anile M et al (2016) Sequential bilateral bronchoscopic lung volume reduction with one-way valves for heterogeneous emphysema. Ann Thorac Surg 102:287–294CrossRef
2.
Zurück zum Zitat Sciurba FC, Ernst A, Herth FJ et al (2010) VENT study research group: a randomized study of endobronchial valves for advanced emphysema. N Engl J Med 363:1233–1244CrossRef Sciurba FC, Ernst A, Herth FJ et al (2010) VENT study research group: a randomized study of endobronchial valves for advanced emphysema. N Engl J Med 363:1233–1244CrossRef
3.
Zurück zum Zitat Herth FJ, Noppen M, Valipour A et al (2012) International VENT study group: efficacy predictors of lung volume reduction with Zephyr valves in a European cohort. Eur Respir J 39:1334–1342CrossRef Herth FJ, Noppen M, Valipour A et al (2012) International VENT study group: efficacy predictors of lung volume reduction with Zephyr valves in a European cohort. Eur Respir J 39:1334–1342CrossRef
4.
Zurück zum Zitat Klooster K, Hacken NH, Hartman JE et al (2015) Endobronchial valves for emphysema without interlobar collateral ventilation. N Engl J Med 373:2325–2335CrossRef Klooster K, Hacken NH, Hartman JE et al (2015) Endobronchial valves for emphysema without interlobar collateral ventilation. N Engl J Med 373:2325–2335CrossRef
5.
Zurück zum Zitat Davey C, Zoumot Z, Jordan S et al (2015) Bronchoscopic lung volume reduction with endobronchial valves for patients with heterogeneous emphysema and intact interlobar fissures (the BeLieVeR-HIFi study): a randomised controlled trial. Lancet 386:1066–1073CrossRef Davey C, Zoumot Z, Jordan S et al (2015) Bronchoscopic lung volume reduction with endobronchial valves for patients with heterogeneous emphysema and intact interlobar fissures (the BeLieVeR-HIFi study): a randomised controlled trial. Lancet 386:1066–1073CrossRef
6.
Zurück zum Zitat Kemp SV, Slebos DJ, Kirk A et al (2017) TRANSFORM study team: a multicenter randomized controlled trial of zephyr endobronchial valve treatment in heterogeneous emphysema (TRANSFORM). Am J RespirCrit Care Med 196:1535–1543CrossRef Kemp SV, Slebos DJ, Kirk A et al (2017) TRANSFORM study team: a multicenter randomized controlled trial of zephyr endobronchial valve treatment in heterogeneous emphysema (TRANSFORM). Am J RespirCrit Care Med 196:1535–1543CrossRef
7.
Zurück zum Zitat Skowasch D, Fertl A, Schwick B et al (2016) LIVE study investigators: a long-term follow-up investigation of endobronchial valves in emphysema (the live study): study protocol and six-month interim analysis results of a prospective five-year observational study. Respiration 92:118–126CrossRef Skowasch D, Fertl A, Schwick B et al (2016) LIVE study investigators: a long-term follow-up investigation of endobronchial valves in emphysema (the live study): study protocol and six-month interim analysis results of a prospective five-year observational study. Respiration 92:118–126CrossRef
8.
Zurück zum Zitat Bach DS, Curtis JL, Christensen PJ et al (1998) Preoperative echocardiographic evaluation of patients referred for lung volume reduction surgery. Chest 114:972–980CrossRef Bach DS, Curtis JL, Christensen PJ et al (1998) Preoperative echocardiographic evaluation of patients referred for lung volume reduction surgery. Chest 114:972–980CrossRef
9.
Zurück zum Zitat Watz H, Waschki B, Meyer T et al (2010) Decreasing cardiac chamber sizes and associated heart dysfunction in COPD: role of hyperinflation. Chest 138:32–38CrossRef Watz H, Waschki B, Meyer T et al (2010) Decreasing cardiac chamber sizes and associated heart dysfunction in COPD: role of hyperinflation. Chest 138:32–38CrossRef
10.
Zurück zum Zitat Fiorelli A, Poggi C, Anile M et al (2019) Visual analysis versus quantitative CT analysis of interlobar fissure integrity in selecting emphysematous patients for endobronchial valve treatment. Interact Cardiovasc Thorac Surg 28(5):751–759CrossRef Fiorelli A, Poggi C, Anile M et al (2019) Visual analysis versus quantitative CT analysis of interlobar fissure integrity in selecting emphysematous patients for endobronchial valve treatment. Interact Cardiovasc Thorac Surg 28(5):751–759CrossRef
11.
Zurück zum Zitat Fiorelli A, Santini M, Shah P (2018) When can computed tomography-fissure analysis replace Chartis collateral ventilation assessment in the prediction of patients with emphysema who might benefit from endobronchial valve therapy? Interact CardiovascThorac Surg 26:313–318CrossRef Fiorelli A, Santini M, Shah P (2018) When can computed tomography-fissure analysis replace Chartis collateral ventilation assessment in the prediction of patients with emphysema who might benefit from endobronchial valve therapy? Interact CardiovascThorac Surg 26:313–318CrossRef
12.
Zurück zum Zitat Laszlo G (2006) Standardization of lung function testing: helpful guidance from the ATS/ERS Task Force. Thorax 61:744–746CrossRef Laszlo G (2006) Standardization of lung function testing: helpful guidance from the ATS/ERS Task Force. Thorax 61:744–746CrossRef
13.
Zurück zum Zitat Welling JBA, Hartman JE, van Rikxoort EM et al (2018) Minimal important difference of target lobar volume reduction after endobronchial valve treatment for emphysema. Respirology 23(3):306–310CrossRef Welling JBA, Hartman JE, van Rikxoort EM et al (2018) Minimal important difference of target lobar volume reduction after endobronchial valve treatment for emphysema. Respirology 23(3):306–310CrossRef
14.
Zurück zum Zitat Spencer KT, Kimura BJ, Korcarz CE et al (2013) Focused cardiac ultrasound: recommendations from the American Society of Echocardiography. J Am Soc Echocardiogr 26:567–581CrossRef Spencer KT, Kimura BJ, Korcarz CE et al (2013) Focused cardiac ultrasound: recommendations from the American Society of Echocardiography. J Am Soc Echocardiogr 26:567–581CrossRef
15.
Zurück zum Zitat Hoeper MM, Bogaard HJ, Condliffe R et al (2013) Definitions and diagnosis of pulmonary hypertension. J Am Coll Cardiol 62:D42–50CrossRef Hoeper MM, Bogaard HJ, Condliffe R et al (2013) Definitions and diagnosis of pulmonary hypertension. J Am Coll Cardiol 62:D42–50CrossRef
16.
Zurück zum Zitat Fiorelli A, Petrillo M, Vicidomini G et al (2014) Quantitative assessment of emphysematous parenchyma using multidetector-row computed tomography in patients scheduled for endobronchial treatment with one-way valves. Interact Cardiovasc Thorac Surg 19:246–255CrossRef Fiorelli A, Petrillo M, Vicidomini G et al (2014) Quantitative assessment of emphysematous parenchyma using multidetector-row computed tomography in patients scheduled for endobronchial treatment with one-way valves. Interact Cardiovasc Thorac Surg 19:246–255CrossRef
17.
Zurück zum Zitat Eberhardt R, Gerovasili V, Kontogianni K et al (2015) Endoscopic lung volume reduction with endobronchial valves in patients with severe emphysema and established pulmonary hypertension. Respiration 89:41–48CrossRef Eberhardt R, Gerovasili V, Kontogianni K et al (2015) Endoscopic lung volume reduction with endobronchial valves in patients with severe emphysema and established pulmonary hypertension. Respiration 89:41–48CrossRef
18.
Zurück zum Zitat Pizarro C, Schueler R, Hammerstingl C et al (2015) Impact of endoscopic lung volume reduction on right ventricular myocardial function. PLoS ONE 10:e0121377CrossRef Pizarro C, Schueler R, Hammerstingl C et al (2015) Impact of endoscopic lung volume reduction on right ventricular myocardial function. PLoS ONE 10:e0121377CrossRef
19.
Zurück zum Zitat Gagnon P, Guenette JA, Langer D et al (2014) Pathogenesis of hyperinflation in chronic obstructive pulmonary disease. Int J Chron Obstruct Pulmon Dis 9:187–201PubMedPubMedCentral Gagnon P, Guenette JA, Langer D et al (2014) Pathogenesis of hyperinflation in chronic obstructive pulmonary disease. Int J Chron Obstruct Pulmon Dis 9:187–201PubMedPubMedCentral
20.
Zurück zum Zitat Oswald-Mammosser M, Kessler R, Massard G et al (1998) Effect of lung volume reduction surgery on gas exchange and pulmonary hemodynamics at rest and during exercise. Am J RespirCrit Care Med 158:1020–1025CrossRef Oswald-Mammosser M, Kessler R, Massard G et al (1998) Effect of lung volume reduction surgery on gas exchange and pulmonary hemodynamics at rest and during exercise. Am J RespirCrit Care Med 158:1020–1025CrossRef
21.
Zurück zum Zitat Caviezel C, Aruldas C, Franzen D et al (2018) Lung volume reduction surgery in selected patients with emphysema and pulmonary hypertension. Eur J Cardiothorac Surg 54:565–571CrossRef Caviezel C, Aruldas C, Franzen D et al (2018) Lung volume reduction surgery in selected patients with emphysema and pulmonary hypertension. Eur J Cardiothorac Surg 54:565–571CrossRef
22.
Zurück zum Zitat Barr RG, Bluemke DA, Ahmed FS et al (2010) Percent emphysema, airflow obstruction, and impaired left ventricular filling. N Engl J Med 362:217–227CrossRef Barr RG, Bluemke DA, Ahmed FS et al (2010) Percent emphysema, airflow obstruction, and impaired left ventricular filling. N Engl J Med 362:217–227CrossRef
23.
Zurück zum Zitat Jörgensen K, Houltz E, Westfelt U et al (2003) Effects of lung volume reduction surgery on left ventricular diastolic filling and dimensions in patients with severe emphysema. Chest 124:1863–1870CrossRef Jörgensen K, Houltz E, Westfelt U et al (2003) Effects of lung volume reduction surgery on left ventricular diastolic filling and dimensions in patients with severe emphysema. Chest 124:1863–1870CrossRef
Metadaten
Titel
Cardio-Pulmonary Changes After Bronchoscopic Lung Volume Reduction with Endobronchial One-Way Valves
verfasst von
Alfonso Fiorelli
Roberto Cascone
Giovanni Natale
Valentina Peritore
Camilla Vanni
Camilla Poggi
Federico Venuta
Erino Angelo Rendina
Mario Santini
Claudio Andreetti
Publikationsdatum
07.04.2020
Verlag
Springer US
Erschienen in
Lung / Ausgabe 3/2020
Print ISSN: 0341-2040
Elektronische ISSN: 1432-1750
DOI
https://doi.org/10.1007/s00408-020-00351-4

Weitere Artikel der Ausgabe 3/2020

Lung 3/2020 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.